 |
인쇄하기
취소
|
Hanmi to get approval of generic Nexium in US
Hanmi Pharm says it has recently filed an ANDA application for its generic Nexium to the U.S. Food and Drug Administration after completion of clinical trials overseas.
The company plans to obtain the market authorization by the end of next year as the US market for Nexium stands at around $3 billion.
Nexium (esomeprazole magnesium) is a proton pump inhibitor developed and marketed by th...
The company plans to obtain the market authorization by the end of next year as the US market for Nexium stands at around $3 billion.
Nexium (esomeprazole magnesium) is a proton pump inhibitor developed and marketed by th...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.